13267
No significant differences between the subcutaneous and intravenous bortezomib formulations were observed in the median time to first response , median progression - free survival , median time to progression and 1 - year overall survival .
 Chemical: bortezomib
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: bortezomib